deltatrials
Completed OBSERVATIONAL NCT03392662

Hemopatch Performance Evaluation: A Prospective Observational Registry

Sponsor: Baxter Healthcare Corporation

Conditions Air Leakage Body Fluid Leakage Dura Mater Nick Cut or Tear Hemostatis
Interventions Hemopatch
Updated 22 times since 2018 Last updated: Nov 14, 2022 Started: Nov 29, 2017 Primary completion: Jan 28, 2019 Completion: Jan 28, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Air Leakage and Body Fluid Leakage, this trial is completed. The trial is conducted by Baxter Healthcare Corporation and has accumulated 22 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2018 – ~Mar 2018 · 59 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~Jun 2019 · 2 months · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Sep 2019 · 2 months · monthly snapshot~Sep 2019 – ~Feb 2020 · 5 months · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshot~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

22 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Dec 2022 — Jul 2024 [monthly]

    Completed

  5. Jan 2021 — Dec 2022 [monthly]

    Completed

▶ Show 17 earlier versions

  1. Feb 2020 — Jan 2021 [monthly]

    Completed

  2. Sep 2019 — Feb 2020 [monthly]

    Completed

    Status: Recruiting → Completed

  3. Jul 2019 — Sep 2019 [monthly]

    Recruiting

  4. Jun 2019 — Jul 2019 [monthly]

    Recruiting

  5. Apr 2019 — Jun 2019 [monthly]

    Recruiting

  6. Mar 2019 — Apr 2019 [monthly]

    Recruiting

  7. Feb 2019 — Mar 2019 [monthly]

    Recruiting

  8. Jan 2019 — Feb 2019 [monthly]

    Recruiting

  9. Dec 2018 — Jan 2019 [monthly]

    Recruiting

  10. Oct 2018 — Dec 2018 [monthly]

    Recruiting

  11. Sep 2018 — Oct 2018 [monthly]

    Recruiting

  12. Aug 2018 — Sep 2018 [monthly]

    Recruiting

  13. Jun 2018 — Aug 2018 [monthly]

    Recruiting

  14. May 2018 — Jun 2018 [monthly]

    Recruiting

  15. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  16. Mar 2018 — Apr 2018 [monthly]

    Recruiting NA

  17. Jan 2018 — Mar 2018 [monthly]

    Recruiting NA

    First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baxter Healthcare Corporation
Data source: Baxter Healthcare Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Barcelona, Spain , Bergisch Gladbach, Germany , Berlin, Germany , Brno, Czechia , Florence, Italy , Girona, Spain , Hamburg, Germany , Innsbruck, Austria , Liberec, Czechia , Madrid, Spain and 4 more locations